Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Bearish
2
Neutral
8
Bullish
4
Bearish
15
Neutral
8
Bullish
23
Bearish
13
Neutral
0
Bullish
19
Market Cap
₹ 206 Cr
P/E
—
Oxygenta Pharmaceutical Limited, formerly S S Organics Ltd, specializes in manufacturing anti-ulcerative and antibacterial drugs, alongside other pharmaceuticals.
The company engages in both contract manufacturing and independent production, supporting its revenue through strategic partnerships.
Oxygenta's production facilities are situated in Medak, Andhra Pradesh, focusing on bulk drugs, including quinolones, antiasthmatic, and anti-inflammatory medications.
Despite operational challenges, such as the 2015 fire accident, Oxygenta has resumed commercial production to stabilize its operations and market position.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs
206 Cr
Moderate Risk
—
59.2
—
—
133.50
52.10
Sales CAGR
1Y
175.73%
3Y
21.78%
5Y
51.45%
10Y
27.33%
Profit CAGR
1Y
-178.16%
3Y
—
5Y
—
10Y
—
ROE
TTM
46.67%
3Y
27.08%
5Y
13.67%
10Y
14.73%
ROCE
TTM
-53.26%
3Y
-65.93%
5Y
-30.23%
10Y
-52.67%
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
55.00 | 206 Cr | — | 0.00 | 0.00 | 46.67 | -53.26 | -14.66 | |
67.06 | 187 Cr | 52.39 | 1.29 | 0.00 | 2.41 | 5.22 | 1.22 | |
128.50 | 172 Cr | 13.97 | 1.24 | 0.61 | 8.89 | 11.28 | 7.20 | |
160.00 | 168 Cr | 31.43 | 3.00 | 0.00 | 8.67 | 10.26 | 3.81 | |
252.80 | 161 Cr | 87.81 | 3.76 | 0.00 | 4.47 | 7.31 | 1.55 | |
32.00 | 155 Cr | 18.88 | 13.34 | 0.00 | 70.62 | 33.57 | 8.06 | |
69.88 | 151 Cr | — | 0.00 | 0.00 | 17.42 | -19.17 | -16.35 |
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
LOW MARGIN
Technicals
Bullish
Risk
MODERATE RISK
Turned 1 L into 7.20 L in last 5 Years
Regulatory Filing
5 days ago
Reclassification of Promoters to Public Category
Oxygenta Pharmaceutical Limited announced the approval of shareholders to reclassify certain promoters to the public category, effective immediately.
Postal Ballot Results
5 days ago
Resolution Passed By Postal Ballot for Reclassification of Promoters
The company announced the passing of a resolution through postal ballot to reclassify certain promoters as public shareholders, following the voting results declared on 11th December 2025.
Postal Ballot Results
5 days ago
Voting Results from Postal Ballot
The Scrutinizers report confirms that a resolution regarding the reclassification of certain promoters to public shareholders was approved by the members through postal ballot.
Postal Ballot Results
5 days ago
Outcome of Postal Ballot
The postal ballot results confirm the approval of the reclassification of certain promoter group members to the 'Public Category' as per SEBI regulations.
